Nov 15, 2019: NIH researchers found that a single, subanesthetic-dose of ketamine infusion was relatively free of side effects for patients with treatment-resistant depression...
Nov 15, 2019: FDA approved Novartis's Adakveo (crizanlizumab-tmca) for the treatment to reduce the frequency of vaso-occlusive crisis in sickle cell disease...
Nov 16, 2019: PRINCETON, N.J. and Bristol-Myers Squibb-Pfizer Alliance announced the initiation of a new randomized controlled trial (GUARD-AF) for undiagnosed atrial fibrillation in elderly...
Nov 16, 2019: USFDA approved Zydus Cadila’s Apremilast tablets for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. The US health regulator...
Nov 14, 2019: The U.S. Food and Drug Administration (FDA) approved Shionogi’s Fetroja (cefiderocol), an antibacterial drug used for the patients of 18 years...